Injection-site reactions Mild redness or small bumps at the injection site are the most commonly reported short-term issues in community usage
Back Sheridan, C (14 April 2025) 'Not just obesity: GLP-1 receptor agonists advance on addiction', Nature Biotechnology , 43, 455-47.Back Sims, EK, Carr, ALJ, Oram, RA, et al (15 July 2022) '100 years of insulin: celebrating the past, present and future of diabetes therapy', Nature Medicine , 27/7, 1154-64
Formulations: Initially available as weekly injections (e.g., Ozempic), they are now also available as oral tablets (e.g., Rybelsus), which improves patient convenience
IV drips higher dosage , makes 2 shade light in first month because of higher dosage administration while IM injections make one shade light in first month
Given its ability to modulate multiple pathways involved in CKD pathogenesis, PTX represents a valuable therapeutic option, particularly for patients with inflammatory or diabetic kidney disease [29]